LatestIP And Trademarks 4 November 2026
Wockhardt Pursues 14‑Year Data Shield for Indian Drugs
Indian pharma company Wockhardt has filed a request for a 14‑year data exclusivity protection for drugs manufactured in India, aiming to secure market advantage without relying on foreign patents. The move targets stronger domestic IP safeguards and could reshape competitive dynamics in the Indian pharmaceutical sector.
Wockhardt is seeking a 14‑year data shield for its India‑made drugs. This protection would prevent competitors from using its clinical data for a decade and a half.
- Applies only to patents granted within India, not overseas filings.
- Intended to boost R&D investment and give Indian manufacturers a longer market window.
- Could set a precedent for future Indian pharmaceutical IP policy.
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.